COG2 Inhibitors
Chemical class COG2 Inhibitors refers to a diverse group of compounds that influence the function of the COG2 protein by targeting various processes and pathways related to the Golgi apparatus and intracellular trafficking. These inhibitors are not specific to COG2 but can indirectly impair its function by disrupting the overall homeostasis and machinery of the Golgi complex. For instance, Brefeldin A and Golgicide A are known for their potent effects on the structure and function of the Golgi, which is essential for the proper functioning of the COG complex including COG2. Both chemicals lead to a disassembly of the Golgi stack and a dispersal of the Golgi enzymes, which undermines the role COG2 plays in maintaining Golgi structure and trafficking.
Further, chemicals like Nocodazole, Monensin, and Exo2 disrupt the Golgi apparatus by interfering with the cytoskeletal network, ion homeostasis, or causing the disassembly of the Golgi stack, respectively. These disruptions can indirectly affect COG2, which relies on a stable Golgi structure to perform its role in vesicle tethering and fusion. On the molecular level, Tunicamycin and Swainsonine impair the proper glycosylation of proteins, which is critical for the function of the Golgi and directly impacts the processing and trafficking roles of COG2. Castanospermine and Deoxynojirimycin, by inhibiting glucosidases, can lead to a buildup of misfolded glycoproteins, exerting stress on the Golgi system.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts the structure of the Golgi apparatus by inhibiting ADP-ribosylation factor (ARF), which is essential for maintaining COG complex function, thus indirectly affecting COG2. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, impairing vesicle transport to and from the Golgi, potentially affecting COG2's role in intracellular trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that disrupts Golgi function by altering pH and cation homeostasis, which can impair the function of Golgi-associated proteins including COG2. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, which is crucial for proper folding and function of Golgi proteins, potentially impacting COG2's stability or function. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Inhibits Golgi alpha-mannosidase II, leading to misprocessing of N-glycans, which can indirectly affect the function of COG2 in glycoprotein trafficking. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Glucosidase inhibitor that can lead to improper glycoprotein processing in the ER and Golgi, potentially disrupting COG2 function. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Inhibitor of glucosidases, affecting glycoprotein maturation in the ER and Golgi and thus possibly impacting COG2's role in trafficking. | ||||||
PAC 1 | 315183-21-2 | sc-203174 sc-203174A | 10 mg 50 mg | $132.00 $536.00 | 1 | |
Disrupts retrograde trafficking from endosomes to the Golgi, which can affect COG2 function by altering cargo delivery to the Golgi. | ||||||
AG14361 | 328543-09-5 | sc-483192 | 5 mg | $255.00 | ||
Small molecule that induces the disassembly of the Golgi, potentially disrupting COG2 function in maintaining Golgi structure. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Non-competitive inhibitor of the GTPase activity of dynamin, affecting vesicle scission and influencing COG2 function in vesicle trafficking. | ||||||